The landscape of dementia diagnosis has evolved drastically with the appearance of innovative biomarkers, including amyloid PET scans, tau imaging, and blood-based mostly tests that may detect Alzheimer's pathology decades just before indicators emerge. Even though these technological innovations signify amazing development in knowing neurodegenera